No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
AKBA240517C1500
- 0.05
- +0.01+25.00%
15min DelayClose May 10 15:58 ET
0.05High0.03Low
0.05Open0.04Pre Close4 Volume2.59K Open Interest1.50Strike Price16.00Turnover230.03%IV28.10%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier5DDays to Expiry0.05Time Value100Contract SizeAmericanOptions Type0.2715Delta0.9611Gamma24.20Leverage Ratio-0.0104Theta0.0000Rho6.57Eff Leverage0.0005Vega
Intraday
- 5D
- 1D
News
Revenue Downgrade: Here's What Analysts Forecast For Akebia Therapeutics, Inc. (NASDAQ:AKBA)
Akebia Therapeutics Reports Q1 2024 Financial Results: A Detailed Overview
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q1 2024 Earnings Call Transcript
Akebia Therapeutics First Quarter 2024 Earnings: Misses Expectations
Akebia Therapeutics(AKBA.US) Officer Sells US$31,050 in Common Stock
$Akebia Therapeutics(AKBA.US)$ Officer Burke Steven Keith sold 27,000 shares of common stock on Aug 25, 2023 at an average price of $1.15 for a total value of $31,050.Source: Announcement What is stat
Tivic Health, RAPT Therapeutics, Notable Labs Among Healthcare Movers
Comments
$Akebia Therapeutics(AKBA.US$ .. what happened?
$Akebia Therapeutics(AKBA.US$ .. ma be drop to below 1
$Akebia Therapeutics(AKBA.US$ Akebia Therapeutics Inc - Term of Supply Agreement Is Extended for an Additional Five Years and Expires on April 2, 2029
4
11
Read more